Company: RPTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103764
Chunk: 22

Company: Repare Therapeutics Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 22
---
 our Vice President of Information Technology regarding cyber security risks and steps taken to mitigate such risks.

Our audit committee oversees risks related to our financial statements, the financial reporting process, accounting, investments, access to capital, currency risk and hedging programs, information security (including risks related to cyber security) and data protection. It meets periodically with management to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. The audit committee also reviews and receives regular briefings concerning information security and technology risks, and monitors ongoing compliance with legal and regulatory requirements.

Our nominating and corporate governance committee reviews the effectiveness of our corporate governance guidelines, including whether they are successful in preventing illegal or improper liability-creating conduct, and monitors compliance with legal, regulatory and ethical requirements. It also reviews and assesses our significant ESG policies and practices, and reviews our risk management procedures for those areas deemed appropriate by the nominating and corporate governance committee.

Our compensation committee assesses and monitors whether any of our compensation policies and programs has the potential to encourage excessive risk-taking, reviews and discusses at least annually the relationship between our risk management policies and practices and compensation, and evaluates compensation policies and practices that could mitigate potential risks.

The full board and its committees receive regular updates on key enterprise risks throughout the year. From time to time, management also completes company-wide risk assessments, focusing on risks that may directly impact Repare achieving its core business and strategic objectives. The results of such assessments are periodically reviewed by the full board and the applicable committees.

Meetings of Our Board of Directors

Our board of directors met seven times during the last fiscal year. Each member of our board of directors attended 75% or more of the aggregate number of meetings of the board and of the committees on which they served, held during the portion of the last fiscal year for which they were a director or committee member.

As required by our Corporate Governance Guidelines, our independent directors meet as required, but no less than two times per year, without members of management or the non-independent directors present. During 2024, our non-employee directors met seven times in regularly scheduled executive sessions at which only non-management directors were present. In addition, each of our board committees consists solely of independent directors and regularly meets at similar executive sessions.

Director Commitments

The nominating and corporate governance committee and our board of directors believe that all directors should have sufficient time and attention to devote to